Palatin Announces Intent to Effect Reverse Stock Split
August 19, 2022
Evofem Biosciences Commends Tri-Agencies for Clarifying that Contraceptives Must be Covered at No Cost to Individuals
July 29, 2022
Related Post
-
-
Todos Medical Announces Preprint of Data from First 100 Participants in IRB-waived Market Research Study of Supplementation with Tollovid in Long COVID
August 19, 2022
-
Qualigen Therapeutics Announces Formation and First Meeting of QN-302 Scientific Advisory Board
August 18, 2022
-
Adial Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
August 16, 2022